![Chaim Hurvitz](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Chaim Hurvitz
Presidente presso DROR ORTHO-DESIGN, INC.
Patrimonio netto: 845 611 $ in data 31/05/2024
Profilo
Chaim Hurvitz is the founder and Chief Executive Officer of CH Health, which was founded in 2011.
He is currently the Chairman of Dror Ortho-Design, Inc. since 2023, Univo Pharmaceuticals Ltd.
since 2019, Shirat Hachaim Ltd., The Institute for the Advancement of Education in Jaffa, Aerodentis, Dror Ortho-Design Ltd.
since 2012, Galmed Medical Research Ltd., Genoscience Pharma, NeuroRx, Inc. since 2015, Celixir Plc, MyBiotics Pharma Ltd.
since 2018, NRX Pharmaceuticals, Inc. since 2021, and the Head-Pharmaceutical Branch of the Manufacturers Association of Israel.
He was previously the President & Chief Executive Officer of Teva Pharmaceuticals Europe BV from 1992 to 1999, Chairman of Galmed Pharmaceuticals Ltd.
from 2011 to 2018, Director of Teva Pharmaceutical Industries Ltd.
from 1999 to 2014, Independent Director of PolyPid Ltd.
from 2016 to 2023, and Director of UroGen Pharma Ltd.
from 2013 to 2017.
Mr. Hurvitz holds an undergraduate degree from Tel-Aviv University, which he received in 1985.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
29/04/2024 | 221 479 ( 2.07% ) | 843 835 $ | 31/05/2024 | |
29/03/2024 | 592 151 ( 4.74% ) | 1 776 $ | 31/05/2024 | |
DROR ORTHO-DESIGN, INC.
-.--% | 17/06/2024 | 0 ( -.--% ) | - $ | 31/05/2024 |
Posizioni attive di Chaim Hurvitz
Società | Posizione | Inizio |
---|---|---|
UNIVO PHARMACEUTICALS LTD | Presidente | 15/07/2019 |
NRX PHARMACEUTICALS, INC. | Direttore/Membro del Consiglio | 24/05/2021 |
DROR ORTHO-DESIGN, INC. | Presidente | 14/08/2023 |
The Institute for the Advancement of Education in Jaffa | Presidente | - |
Dror Ortho-Design Ltd.
![]() Dror Ortho-Design Ltd. Medical/Nursing ServicesHealth Services Part of Novint Technologies, Inc., Dror Ortho-Design Ltd. provides dental services. The company is based in Jerusalem, Israel. Eliyahu Haddad has been the CEO of the Israeli company since 2021. Dror Ortho-Design was acquired by Novint Technologies, Inc. on August 21, 2023. | Presidente | 17/01/2012 |
Genoscience Pharma
![]() Genoscience Pharma BiotechnologyHealth Technology Genoscience Pharma is a French clinical-stage biotechnology company that develops novel lysosomotropic therapeutics to establish a new standard of care against cancer, autoimmune, and infectious diseases. The private company is based in Marseille, France and was founded in 2001 by Philippe Halfon. Its lead candidate, GNS561, is a phase 2 ready drug candidate that tackles cancer cells through autophagy modulation. Genoscience Pharma is also entering a phase 2 trial with GNS561. | Direttore/Membro del Consiglio | - |
MyBiotics Pharma Ltd.
![]() MyBiotics Pharma Ltd. BiotechnologyHealth Technology MyBiotics Pharma Ltd. operates as a micro biome pharmaceutical company that develops live bacteria based drugs. It develops MyCrobe and SuperDonor technologies for growing specific bacterial communities on pre-selected particles for stable and resistant raw material and for multi bacterial products. The company was founded in and is headquartered in Ness Ziona, Israel. | Direttore/Membro del Consiglio | 01/01/2018 |
Celixir Plc
![]() Celixir Plc Pharmaceuticals: MajorHealth Technology Celixir Plc discovers and develops regenerative medicines to treat life threatening and life altering diseases. It offers heartcel-immunomodulatory progenitor imp cells, tendoncel-platelet lysate based therapy, myocardion-progenitor cells of mesodermal lineage. The company was founded by Martin Evans and Ajan Reginald in 2009 and is headquartered in Stratford-upon-Avon, the United Kingdom. | Direttore/Membro del Consiglio | - |
Aerodentis | Presidente | - |
░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
Precedenti posizioni note di Chaim Hurvitz
Società | Posizione | Fine |
---|---|---|
░░░░░░░ ░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░ ░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░ ░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
░░░░ ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
Formazione di Chaim Hurvitz
Tel-Aviv University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 8 |
---|---|
TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Health Technology |
DROR ORTHO-DESIGN, INC. | Electronic Technology |
UNIVO PHARMACEUTICALS LTD | Health Technology |
POLYPID LTD. | Health Technology |
UROGEN PHARMA LTD. | Health Technology |
GALMED PHARMACEUTICALS LTD. | Health Technology |
VIEWBIX INC. | Electronic Technology |
NRX PHARMACEUTICALS, INC. | Health Technology |
Aziende private | 17 |
---|---|
Aposense Ltd.
![]() Aposense Ltd. Pharmaceuticals: MajorHealth Technology Aposense Ltd. engages in the provision of proprietary conjugates. It offers platform technology which comprises the rational design of small molecular moieties with the increased affinity to the cell membranes imparting the conjugates compound with improved drug properties such as extended life span oral bioavailabity and selective at target site. The company was founded by Ilan Ziv and Jacob Gottenstein on October 9, 1996 and is headquartered in Petach-Tikva, Israel. | Health Technology |
Teva Pharmaceuticals Europe BV
![]() Teva Pharmaceuticals Europe BV MiscellaneousMiscellaneous Part of Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals Europe BV operates as an investment holding Dutch company and wholesales pharmaceutical goods and raw materials. The company is based in Haarlem, Netherlands. | Miscellaneous |
Galmed Medical Research Ltd. | |
Manufacturers Association of Israel
![]() Manufacturers Association of Israel Miscellaneous Commercial ServicesCommercial Services The Manufacturers Association of Israel is an organization that has been serving as an umbrella organization for industrialists for over 90 years. The non-profit company is based in Tel Aviv, Israel. It has around 2,000 member companies in the industry and hi-tech sectors, employing approximately 400,000 workers. The association provides a wide range of support and services at both the national and corporate levels. Every year, the association awards the Industry Awards and the Lifetime Achievement Awards in Industry. Israeli industry plays a significant role in various aspects of life, including defense, immigrant absorption, support for outlying regions, education, and the community. | Commercial Services |
Israel Diamond Manufacturers Association Ltd.
![]() Israel Diamond Manufacturers Association Ltd. Miscellaneous Commercial ServicesCommercial Services Israel Diamond Manufacturers Association Ltd. engages in the advancement of the diamonds industry and the unification of diamonds producers. The company was founded in 1940 and is headquartered in Ramat Gan, Israel. | Commercial Services |
Cell Therapy Ltd.
![]() Cell Therapy Ltd. BiotechnologyHealth Technology Cell Therapy Ltd. produces regenerative medicines using adult stem cells to treat heart failure. Its product HeartCel, a stem cell therapy that offers improved outcomes for heart failure patients by reducing the size of heart scar, improving heart function, quality of life and reducing mortality. The firm develops therapies based on the adult mesenchymal stromal cells technology platform. The firm’s regenerative therapies will focus on curing the cause of the disease, rather than only treating the symptoms. The company was founded in 2009 by Martin John Evans and Ajan Trevor Reginald and is headquartered in Cardiff, the United Kingdom. | Health Technology |
Genoscience Pharma
![]() Genoscience Pharma BiotechnologyHealth Technology Genoscience Pharma is a French clinical-stage biotechnology company that develops novel lysosomotropic therapeutics to establish a new standard of care against cancer, autoimmune, and infectious diseases. The private company is based in Marseille, France and was founded in 2001 by Philippe Halfon. Its lead candidate, GNS561, is a phase 2 ready drug candidate that tackles cancer cells through autophagy modulation. Genoscience Pharma is also entering a phase 2 trial with GNS561. | Health Technology |
CH Health | |
Shirat Hachaim Ltd. | |
The Institute for the Advancement of Education in Jaffa | |
Emerald Medical Applications Ltd.
![]() Emerald Medical Applications Ltd. Medical SpecialtiesHealth Technology Emerald Medical Applications Ltd. was engaged in the provision of medical apparatus software solutions. The company was founded by Adi Zamir and Lior Wayn on February 17, 2010 and was headquartered in Modi'in-Maccabim-Re'ut, Israel. | Health Technology |
NeuroRx, Inc.
![]() NeuroRx, Inc. BiotechnologyHealth Technology NeuroRx, Inc. operates as a clinical stage, small molecule pharmaceutical company developing novel therapeutics for the treatment of central nervous system disorders. The company was founded by Jonathan C. Javitt and Daniel C. Javitt in 2015 and is headquartered in Wilmington, DE. | Health Technology |
Celixir Plc
![]() Celixir Plc Pharmaceuticals: MajorHealth Technology Celixir Plc discovers and develops regenerative medicines to treat life threatening and life altering diseases. It offers heartcel-immunomodulatory progenitor imp cells, tendoncel-platelet lysate based therapy, myocardion-progenitor cells of mesodermal lineage. The company was founded by Martin Evans and Ajan Reginald in 2009 and is headquartered in Stratford-upon-Avon, the United Kingdom. | Health Technology |
MyBiotics Pharma Ltd.
![]() MyBiotics Pharma Ltd. BiotechnologyHealth Technology MyBiotics Pharma Ltd. operates as a micro biome pharmaceutical company that develops live bacteria based drugs. It develops MyCrobe and SuperDonor technologies for growing specific bacterial communities on pre-selected particles for stable and resistant raw material and for multi bacterial products. The company was founded in and is headquartered in Ness Ziona, Israel. | Health Technology |
Aerodentis | |
CTG Weld Ltd.
![]() CTG Weld Ltd. Miscellaneous Commercial ServicesCommercial Services CTG Weld Ltd. is a contract research organization that conducts clinical trials in various therapeutic areas. The private company is located in Cyprus. | Commercial Services |
Dror Ortho-Design Ltd.
![]() Dror Ortho-Design Ltd. Medical/Nursing ServicesHealth Services Part of Novint Technologies, Inc., Dror Ortho-Design Ltd. provides dental services. The company is based in Jerusalem, Israel. Eliyahu Haddad has been the CEO of the Israeli company since 2021. Dror Ortho-Design was acquired by Novint Technologies, Inc. on August 21, 2023. | Health Services |
- Borsa valori
- Insiders
- Chaim Hurvitz